VIC GROUP's Clavuxicin: A Winner in the National Zoobusiness Rating

Based on findings of the National Zoobusiness Rating organized by the information portal Zooinform, the antibacterial Clavuxicin won the Novelty of the Year in the “Veterinary Medicines” category. 

Clavuxicin is a broad-spectrum combination antibiotic for cats and dogs with proven efficacy against bacterial infections of the skin, urinary tract, respiratory system and the GIT. This product, supported by the professional community, scored an impressive 92.7 points.

Five more VIC GROUP products took high places in the rating:

• Avecardit heart failure medication for dogs: second place;
• Firoko non-steroidal anti-inflammatory product: fourth place;
• Soladoxi Tetracycline antibiotic: fifth place;
• Pinpramil anthelmintic: seventh place;
• Hollicalm antiemetic: ninth place.

“We thank the organizers and the professional community for their appreciation of the quality and efficacy of our products.  Six products out of ten in this category are manufactured by VIC GROUP —testament to the well-deserved trust veterinary physicians and experts put in the company's products. This achievement was made possible by VIC GROUP's innovation-based manufacturing, which is in a class with the world's pharmaceutical giants and certified according to international GMP standards”, noted Vladislav Pshenichny, VIC GROUP's Director of the Small Domestic Animals Division.

The National Zoobusiness Rating includes 72 new products that appeared on the Russian animal health market in 2024 in key categories for companion animals. The ranking system works in several stages. First, 11 independent experts: technologists, breeders, veterinary physicians and marketing specialists, evaluate each product on a 10-point scale based on criteria such as innovation, appearance, performance characteristics and market demand. Then a professional audience is engaged for evaluation: an open vote is conducted in Zooinform's social media for a month, making the rating extremely objective and protected against artificial interference.